<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090706 Figure_1-A</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Structure of Brca1ex2 allele. * Note that exon 4 was annotated in error in original descriptions of the gene structure and is not drawn. RT-PCR shows a novel product from the Brca1ex2 allele, corresponding to splicing of exon 1 directly to exon 3.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_1-B</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Western blot to detect BRCA1 and BARD1 in MEFs expressing WT and mutant Brca1.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_1-C-D-E</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 1-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C. Immunofluorescent (IF) detection of BRCA1 and RAD51 at IR-induced nuclear foci in cells expressing WT and mutant forms of Brca1. Scale bar: 10 ing D. Quantification of IF, showing proportion of cells with RAD51 foci that also had &gt;5 BRCA1 foci. N=2. E. Quantification of IF, showing proportion of RAD51 foci that colocalized with BRCA1 foci. N=2.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_1-F</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Immunofluorescent detection of BARD1 at IR-induced nuclear foci in MEFs expressing WT and mutant forms of Brca1. Scale bar: 10 &#956; S</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-A</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Western blot showing abundance of BRCA1 and BARD1 protein in Brca1&#916;2/&#916;2;Trp53bp1-/- mouse B cells.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-B</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Analysis of chromosome aberrations in mice with targeted deletion of Brca1 exon 2 and Trp53bp1. Left, metaphase spreads were prepared from B cells treated with olaparib. Arrows show examples of chromosome aberrations. Right, quantification of chromosome breaks (CSB), chromatid-type breaks (CTD), radial chromosomes, and other abnormalities in mouseB cells. Error bars indicate SD, N=3</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-C</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. RAD51 foci in B cells after 10 Gy IR exposure. Chart shows mean percentage of cells with &gt;5 foci, N=3. Error bars indicate SD, statistical analysis by two-tailed Student t test.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-D</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Percentage of cells showing &gt;5 RAD51 foci after 4hrs treatment with 10 &#956;M olaparib (OLA) or 10 &#956;M camptothecin (CPT). N=2.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-E</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Average number of &#947;-H2AX foci per cell in cells that were not treated (NT) or exposed to 2 Gy ionizing radiation. N=2.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_2-F</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Sister chromatid exchanges in cells that were not treated (NT) or exposed to 2 &#956;M olaparib (OLA) for 16 hrs. Black arrows in images show SCEs in olaparib-treated cells. Scale bar: 5 &#956;m. N=2.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_3-A-D</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 3-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A. Experimental scheme and representative images of DNA fibers. Scale bar: 5 &#956;m. B. Analysis of fibers showing proportions of replication forks that showed restart after HU treatment or remained stalled. N=2, &gt;500 fibers scored per experiment. C. Proportion of total forks showing de novo initiation after HU treatment. N=2, &gt;500 fibers scored per experiment. D. Length of initial replication fork tracts (CldU tracts). N=2, &gt;200 fibers measured per experiment.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_4-A</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Kaplan-Meier survival curve for Brca1ex2/+;Trp53bp1-/- and Brca1ex2/ex2;Trp53bp1-/- mice. N=20 animals in each group. Statistical analysis by Mantel-Cox log-rank test.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_4-B</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Kaplan-Meier survival curve for Brca1ex2/+;Trp53bp1-/-;Trp53+/- and Brca1ex2/ex2;Trp53bp1-/-;Trp53+/- mice. N=20 animals in each group. Statistical analysis by Mantel-Cox log-rank test.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_4-C</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Percentage of Brca1ex2/+;Trp53bp1-/- and Brca1ex2/ex2;Trp53bp1-/- mice showing signs of abnormal tissue morphology at death. N=46 animals inspected for Brca1ex2/+;Trp53bp1+/+, N=54 animals inspected for Brca1ex2/ex2/Trp53bp1-/-.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_4-D</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Tissues affected by abnormal growth from N=46 Brca1ex2/+/Trp53bp1-/- and N=54 Brca1ex2/ex2/Trp53bp1-/- mice.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_5-A</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. H&amp;E-stained sections of seminiferous tubules from testes of WT and Brca1ex2/ex2/Trp53bp1-/- male mice. Scale bar: 100 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_5-B</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Immunofluorescence on meiotic chromosomes from WT and Brca1ex2/ex2;Trp53bp1-/-spermatocytes. Spreads were stained for SYCP3 to indicate chromosome axes and extent of synapsis and were stained for SYCP3 to indicate chromosome axex body. Scale bar: 5 apsi</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_5-C</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Quantification of the number of &#947;-H2AX foci observed at the pachytene stage in the indicated genotypes. P value is Mann-Whitney, two-tailed.</text>
    </passage>
  </document>
  <document>
    <id>5090706 Figure_5-D</id>
    <infon key="sourcedata_document">2306</infon>
    <infon key="doi">10.15252/embr.201642497</infon>
    <infon key="pmc_id">5090706</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. G2M checkpoint analysis in mouse B cells after IR treatment. Left, mitotic cells were identified by flow cytometry as having 4c DNA content (based on propidium iodide staining) and pSer10-H3+. Right, quantification of flow cytometry data, showing mitotic cells after IR as percentage of that seen in untreated cells. N&#8805;2.</text>
    </passage>
  </document>
</collection>
